Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: Our experience using 131I—B72.3
- 31 December 1989
- journal article
- Published by Elsevier in International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology
- Vol. 16 (2) , 127-135
- https://doi.org/10.1016/0883-2897(89)90183-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancerNuclear Medicine Communications, 1988
- Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinomaCancer, 1988
- The Use and Abuse of Imaging in Gynecologic CancerCancer, 1987
- Pros and cons of gynecologic tumor markersCancer, 1987
- Tumor‐associated glycoprotein (TAG‐72) detected in adenocarcinomas and benign lesions of the stomachInternational Journal of Cancer, 1986
- Ovarian cancerNuclear Medicine Communications, 1984
- A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor‐associated antigen in human mammary carcinoma cell populationsInternational Journal of Cancer, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITYBiochemical Journal, 1963